Health Care & Life Sciences » Biotechnology | AMAG Pharmaceuticals Inc.

AMAG Pharmaceuticals Inc.

AMAG Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$6.4
Market Cap
$337.67 M
Shares Outstanding
33.77 M
Public Float
33.53 M

Profile

Address
1100 Winter Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.amagpharma.com
Updated 07/08/2019
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases.

Financials

View All
Created with Highcharts 5.0.14AMAG Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.9 6029 602135 817135 81732 77932 7792 4832 483199 228199 228169 339169 339201320142015201620172018050k100k150k200k250k
Created with Highcharts 5.0.14AMAG Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.80 85680 856124 384124 384418 276418 276532 091532 091609 946609 946474 002474 0022013201420152016201720180200k400k600k800k

William K. Heiden
President, Chief Executive Officer & Director
Gino Santini
Chairman